Quantum-Si Inc Ordinary Shares - Class A QSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
-
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
-
Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
-
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
-
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
Quantum-Si Reports Second Quarter 2024 Financial Results
-
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
Trading Information
- Previous Close Price
- $0.84
- Day Range
- $0.84–0.91
- 52-Week Range
- $0.73–2.43
- Bid/Ask
- $0.86 / $0.91
- Market Cap
- $125.28 Mil
- Volume/Avg
- 299,201 / 537,607
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 73.30
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 165
- Website
- https://www.quantum-si.com
Comparables
Valuation
|
Metric
|
QSI
|
688253
|
002030
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 21.74 | 12.70 |
Price/Book Value | 0.54 | 3.00 | 1.07 |
Price/Sales | 73.30 | 8.86 | 8.73 |
Price/Cash Flow | — | 17.00 | 15.08 |
Price/Earnings
QSI
688253
002030
Financial Strength
|
Metric
|
QSI
|
688253
|
002030
|
|---|---|---|---|
Quick Ratio | 19.87 | 15.40 | 2.15 |
Current Ratio | 20.57 | 15.84 | 4.15 |
Interest Coverage | — | 2,238.82 | −78.04 |
Quick Ratio
QSI
688253
002030
Profitability
|
Metric
|
QSI
|
688253
|
002030
|
|---|---|---|---|
Return on Assets (Normalized) | −31.21% | 12.17% | −5.89% |
Return on Equity (Normalized) | −34.04% | 13.13% | −7.30% |
Return on Invested Capital (Normalized) | −36.19% | 12.68% | −7.42% |
Return on Assets
QSI
688253
002030
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Bmsbywfxt | Kgfxsk | $196.0 Bil | |||
| Stryker Corp
SYK
| Gvsxywnw | Hcl | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Rqcwpqkqw | Sshkhy | $124.5 Bil | |||
| Medtronic PLC
MDT
| Xpplfwk | Kbxnyw | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Cnkppzvfg | Mbjnxqq | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Qppr | Tggnp | $30.2 Bil | |||
| DexCom Inc
DXCM
| Kscqxtpgz | Fdqj | $27.3 Bil | |||
| Steris PLC
STE
| Zhwqwtgy | Gskftj | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Htntrmcqzq | Njqwp | $21.3 Bil | |||
| Insulet Corp
PODD
| Trswxxnmg | Bqhzsj | $16.1 Bil |
United States